We are practicing medicine in a world where toxicant exposure complexed with acute and chronic infections inhabit and complicate the landscape of human health – where immunity to viruses and other pathogens, like Lyme and its co-infections, are increasingly compromised by toxicants.

Addressing the complex intersection between COVID-19, cardiometabolic disease, environmental exposures, and immunity requires an approach that addresses all these components and EHS 2022 will provide the comprehensive treatment strategies that doctors need most.

EHS Objectives:

• Understanding and treating Inflammation, toxicants, and post viral syndrome

• Identifying and treating the issues related to vascular and thrombotic clotting potential

• Addressing the complex intersection of immune/toxicant exposure

• How toxicant exposure predisposes us to viral infection and where to begin to unravel the antecedents